1 / 8

Head & Neck Cancer Drugs Market worth $2,281 Mn by 2025

The global head & neck cancer drugs market was valued at $1,295 million in 2017, and is expected to reach $2,281 million by 2025, growing at a CAGR of 7.3% from 2018 to 2025.

sanketsolanki
Download Presentation

Head & Neck Cancer Drugs Market worth $2,281 Mn by 2025

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Head & Neck Cancer Drugs Marketto Reach $2,281 Million by 2025

  2. Introduction • The global head & neck cancer drugs market was valued at $1,295 million in 2017, and is expected to reach $2,281 million by 2025, growing at a CAGR of 7.3% from 2018 to 2025. • Head & neck cancer drugs include chemotherapy and targeted & immune therapeutic drugs, which are used alone or in combination for treatment of throat, larynx, nose, sinuses, lips, salivary glands, and mouth cancers.  • Increase in prevalence of head & neck cancer across geographies, rise in demand for combination therapy for management of head & neck cancer, drive the market growth. • Technological advancements in screening procedure for cancer and strong presence of pipeline drugs such as Ipilimumab, Atezolizumab, Avelumab, Durvalumab, Erlotinib, Afatinib, Bevacizumab, and others are expected to drive the market growth. 

  3. Based on sales channel, the online stores segment is expected to experience fastest market and is projected to grow at a CAGR of 10.2% during the forecast period 2018-2025. • Depending on drug class, the chemotherapy segment held nearly half of the global market share in 2017, and is projected to grow at a CAGR of 4.0% from 2018 to 2025. • Region wise, Asia-Pacific is expected to experience growth at the highest rate, registering a CAGR of 9.7% during the forecast period. Key Findings of theMarket Get Access to TOC / Sample Report @ https://www.alliedmarketresearch.com/request-sample/5174

  4. The study provides an in-depth analysis of the market along with the current head & neck cancer drugs market trends and future estimations to elucidate the imminent investment pockets. • It offers a quantitative analysis from 2017 to 2025, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities. • Head & neck cancer drugs market forecast is studied from 2018 to 2025. • A comprehensive analysis of all the geographical regions is provided to determine the prevailing opportunities. • Head & neck cancer drugs market size and estimations are based on a comprehensive analysis of key developments in the head and neck cancer drugs industry. Key Benefits

  5. By Drug Class • Chemotherapy • Immunotherapy • Targeted Therapy • By Sales Channel • Hospital Pharmacies • Drug Stores & Retail Pharmacies • Online Stores MarketSegmentation • By Region • North America • Europe • Asia-Pacific • LAMEA

  6. AstraZeneca PLC, • Bristol-Myers Squibb Company, • Eli Lilly and Company (ARMO Biosciences), • Fortress Biotech, Inc. (Checkpoint Therapeutics, Inc.),  • F. Hoffmann-La Roche Ltd. (Genentech, Inc.),  • Others Key Players of theMarket For purchase enquiry, visit @https://www.alliedmarketresearch.com/purchase-enquiry/5174

  7. About Allied MarketResearch: Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions". AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective marketdomain. ContactUs: 5933 NE Win Sivers Drive, #205, Portland, OR 97220, UnitedStates. Int'l: +1-503-894-6022 TollFree: +1-800-792-5285 Fax: +1-800-792-5285 Contact Allied MarketResearch

  8. ThankYou! For MoreDetails Visit usat https://www.prnewswire.com/news-releases/head--neck-cancer-drugs-market-to-reach-2-2-bn-by-2025--globally-at-7-3-cagr-allied-market-research-300803262.html Follow UsOn:

More Related